Accentuating the caveat emptor perspective with critical commentary on financial disclosure. I adopt a skeptical persona and look for chinks in the teflon coating of financial disclosure. My job is to identify financial warts. Perhaps a Black Swan. Disclosure: I do not hold positions in stocks mentioned for three trading days before or after blog post.
Monday, September 18, 2006
Centene Investors Suffer
Centene Corp (NYSE:CNC) has its hands full; firstly with earnings difficulties and lately losing in Kansas as a Medicaid provider. Watch the analyst behavior. Guidance is difficult when predicting government actions. They all are waiting for Q3 results. But in this case quarterlies will most likely reveal nothing. Management needs to shed some light on why they think they lost Kansas and what they are doing about it. In the meantime management and analyst statements will not be helpful. Most recommendations are neutral to bearish. Investors are on their own and suffering financially. Of course if some good news comes out the analysts will all issue buy signals and drive the price up. Its called a stampede.